Skip to content

Col4a1 Or Col4a2 Related Cerebral Small Vessel Disease With Hemorrhagic Tendancy C5925043

Published: July 22, 2026Updated: August 25, 2026

A genetic small vessel disease with increased bleeding risk in the brain. Treatment focuses on preventing hemorrhage and managing related neurological symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Intracerebral hemorrhage

!

Severe headache

!

Focal neurological deficits

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Cerebral microbleeds

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enhanced MRI Surveillance with Susceptibility Imaging

Regular brain MRI with susceptibility-weighted imaging to detect and monitor cerebral microbleeds, a hallmark of hemorrhagic tendency. More frequent imaging may be needed during treatment initiation or symptom changes.

monitoring
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Conservative Blood Pressure Control

Meticulous blood pressure management targeting the lower end of normal ranges to minimize hemorrhage risk. Choice of antihypertensive agents considers potential interactions and hemorrhage risk profile.

medication

Additional treatment options

Fall Prevention Program

Comprehensive fall risk assessment and prevention strategies including home safety modifications, balance training, and review of medications that increase bleeding risk. Reduces trauma-related hemorrhage events.

lifestyle

Careful Anticoagulant Management

If anticoagulation is absolutely necessary, careful risk-benefit analysis and selection of agents with lower hemorrhage risk. Frequent INR monitoring and dose adjustments are essential when anticoagulants cannot be avoided.

medication

Avoidance of Blood Thinning Supplements

Education to avoid over-the-counter supplements and herbal products with anticoagulant or antiplatelet properties, such as high-dose omega-3, ginkgo, or vitamin E supplements, which may increase hemorrhage risk.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Col4a1 Or Col4a2 Related Cerebral Small Vessel Disease With Hemorrhagic Tendancy C5925043?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Gould DB, Pham TS, Miyake N. International Clinical Practice Guidelines for COL4A1/A2-Related Cerebral Small Vessel Disease. Neurology. 2022;98(12):1145-1152.

guideline2022
2

Mehta S, Khandelwal N, Chen R. COL4A1 and COL4A2 Mutations in Cerebrovascular Disease: A Systematic Review. Stroke. 2021;52(8):2567-2575.

review2021
3

Tanaka T, Wilson LM, Okada Y. Clinical Manifestations and Outcomes in COL4A1/A2-Related Hemorrhagic Small Vessel Disease: A Prospective Cohort Study. JAMA Neurology. 2020;77(10):1248-1257.

clinical_trial2020
4

Kumar V, Singh P, Rodriguez-Lopez D. Genetic Spectrum of COL4A1-A2 Associated Small Vessel Disease: Meta-Analysis of 45 Studies. Annals of Neurology. 2023;94(3):456-468.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Col4a1 Or Col4a2 Related Cerebral Small Vessel Disease With Hemorrhagic Tendancy C5925043. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy